SCHEMBL30097961

SCHEMBL30097961

CC(=O)N[C@@H]1[C@@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O)[C@@H]2O)[C@@H](CO)O[C@@H]1O

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ LGALS3 P17931 6/20 0.59
▸ LGALS8 O00214 1/20 0.59
▸ LGALS4 P56470 1/20 0.59
▸ MAPK1 P28482 2/20 0.53
▸ CD209 Q9NNX6 2/20 0.47
▸ CD69 Q07108 1/20 0.47
▸ CHIA Q9BZP6 1/20 0.46
▸ ENGASE Q8NFI3 1/20 0.46
▸ FGF1 P05230 1/20 0.46
▸ FGF2 P09038 1/20 0.46
▸ VEGFA P15692 1/20 0.46
▸ HPSE Q9Y251 1/20 0.46
▸ LGALS1 P09382 1/20 0.46
▸ LGALS7; LGALS7B P47929 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ THRB P10828 1/20 0.46
▸ AMY2A P04746 1/20 0.45
▸ LGALS9 O00182 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5527986 0.97 LGALS3 (0.62) LGALS3LGALS8LGALS4MAPK1CD69
SCHEMBL18867406 0.97 LGALS3 (0.62) LGALS3LGALS8LGALS4MAPK1CD69
SCHEMBL19579354 0.97 LGALS3 (0.62) LGALS3LGALS8LGALS4MAPK1CD69
SCHEMBL6806198 0.97 LGALS3 (0.62) LGALS3LGALS8LGALS4MAPK1CD69
SCHEMBL6806201 0.97 LGALS3 (0.62) LGALS3LGALS8LGALS4MAPK1CD69
SCHEMBL17777302 0.97 LGALS3 (0.62) LGALS3LGALS8LGALS4MAPK1CD69
SCHEMBL34473199 0.97 LGALS3 (0.62) LGALS3LGALS8LGALS4MAPK1CD69
SCHEMBL29399861 0.97 LGALS3 (0.62) LGALS3LGALS8LGALS4MAPK1CD69
SCHEMBL29399259 0.94 LGALS3 (0.63) LGALS3LGALS8LGALS4MAPK1CD69
SCHEMBL1078078 0.94 LGALS3 (0.65) LGALS3LGALS8LGALS4MAPK1CD69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11643450-B2 Chemoenzymatic glycoengineering of antibodies and Fc fragments thereof UNIVERSITY OF MARYLAND, BALTIMORE (US) 2023-05-09 — — US disclosed
EP-2812442-B9 CHEMOENZYMATIC GLYCOENGINEERING OF ANTIBODIES AND FC FRAGMENTS THEREOF UNIV MARYLAND (US) 2023-02-15 — — EP disclosed
EP-2812442-B1 CHEMOENZYMATIC GLYCOENGINEERING OF ANTIBODIES AND FC FRAGMENTS THEREOF UNIV MARYLAND (US) 2022-11-30 — — EP disclosed
Send feedback